Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China
ABCD has a clinical efficacy comparable to AmB-D, with higher symptom remission rate, lower nephrotoxicity, and lower bone marrow suppression, indicating that ABCD may be an appropriate alternative option for the clinical management of talaromycosis.
Authors
- Qian Liu (ORCID: https://orcid.org/0000-0002-1926-4511)
- Kun He (ORCID: https://orcid.org/0000-0002-0587-2313)
- Yaokai Chen (ORCID: https://orcid.org/0000-0002-3229-0108)
- Jing Yuan (ORCID: https://orcid.org/0000-0002-8937-9568)
- Honghong Yang (ORCID: https://orcid.org/0000-0002-8210-6217)
- Min Liu (ORCID: https://orcid.org/0000-0002-0925-1071)
Institutions
- Chongqing Public Health Medical Center (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/idr.s481856
- Citations
- 3
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.17